THE USING OF CONCOR AFFECT THE RISK OF ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE

During the analysis of data on participants in the REACH registry, results were obtained that indicate that the use of beta-blockers in patients with coronary artery disease, both those who have not had myocardial infarction and those who have had myocardial infarction, as well as in persons without coronary heart disease, but with high risk of developing diseases associated with atherosclerosis is not accompanied by a decrease in the incidence of complications of cardiovascular diseases.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-10-31
DOI
https://doi.org/10.5281/zenodo.14015824
Primary Topic
Healthcare Systems and Public Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

THE USING OF CONCOR AFFECT THE RISK OF ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE

Zenodo (CERN European Organization for Nuclear Research)
Healthcare Systems and Public Health
article

THE USING OF CONCOR AFFECT THE RISK OF ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE

article en

Abstract

During the analysis of data on participants in the REACH registry, results were obtained that indicate that the use of beta-blockers in patients with coronary artery disease, both those who have not had myocardial infarction and those who have had myocardial infarction, as well as in persons without coronary heart disease, but with high risk of developing diseases associated with atherosclerosis is not accompanied by a decrease in the incidence of complications of cardiovascular diseases.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 56%
Healthcare Systems and Public Health
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

THE USING OF CONCOR AFFECT THE RISK OF ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS